04:55 GMT27 October 2020
Listen Live
    World
    Get short URL
    0 33
    Subscribe

    NIAID Director Anthony Fauci said that US National Institute of Allergy and Infectious Diseases will start the first human clinical trial phase of a Zika vaccine in the beginning of August.

    WASHINGTON (Sputnik) The US National Institute of Allergy and Infectious Diseases (NIAID) will start the first human clinical trial phase of a Zika vaccine in the beginning of August, NIAID Director Anthony Fauci said on Friday.

    "We have a number of vaccine candidates, the first one…is a DNA vaccine candidate. We will be going into phase 1 trials in humans within the next couple of weeks, sometime in early August," Fauci said at the Bipartisan Policy Center.

    The trial will include 80 participants and take place outside of Washington, DC at the NIAID national center in Bethesda, Maryland.

    Fauci warned that the emergence of the mosquito-borne Zika virus is part of a "pandemic in process," with more than 5,000 documented cases in the United States and its territories.

    The Zika virus does not cause serious complications in infected individuals, but it can cause developmental abnormalities in infants, like microcephaly. The disease is primarily spread through mosquitos, but can also be transmitted from mother to child, sexually, and as a result of blood transfusions.

    Related:

    67 Countries Have Evidence of Zika Virus Transmission Since 2007
    Florida Probes 2 Zika Cases Possibly Spread by Mosquitoes
    Colombian Health Ministry Declares Zika Outbreak Over
    US Awards $60Mln to States, Territories to Battle Zika
    Tags:
    vaccine, Zika Virus, NIAID, US
    Community standardsDiscussion